These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35621078)

  • 21. TP53-induced glycolysis and apoptosis regulator (TIGAR) ameliorates lysosomal damage in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-mediated mouse model of Parkinson's disease.
    Ge J; Lin H; Yang J; Li Q; Zhou J; Qin Z; Wu F
    Toxicol Lett; 2021 Mar; 339():60-69. PubMed ID: 33359019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of TP53-induced glycolysis and apoptosis regulator (TIGAR) as the phosphoglycolate-independent 2,3-bisphosphoglycerate phosphatase.
    Gerin I; Noël G; Bolsée J; Haumont O; Van Schaftingen E; Bommer GT
    Biochem J; 2014 Mar; 458(3):439-48. PubMed ID: 24423178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
    Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
    Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
    Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
    J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux.
    Fu J; Yu S; Zhao X; Zhang C; Shen L; Liu Y; Yu H
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
    Sam F; Duhaney TA; Sato K; Wilson RM; Ohashi K; Sono-Romanelli S; Higuchi A; De Silva DS; Qin F; Walsh K; Ouchi N
    Endocrinology; 2010 Jan; 151(1):322-31. PubMed ID: 19850745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pressure Overload Impairs Cardiac Function in Long-Chain Fatty Acid Transporter CD36-Knockout Mice.
    Nakatani K; Masuda D; Kobayashi T; Sairyo M; Zhu Y; Okada T; Naito AT; Ohama T; Koseki M; Oka T; Akazawa H; Nishida M; Komuro I; Sakata Y; Yamashita S
    Int Heart J; 2019 Jan; 60(1):159-167. PubMed ID: 30518717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.
    Salatzki J; Foryst-Ludwig A; Bentele K; Blumrich A; Smeir E; Ban Z; Brix S; Grune J; Beyhoff N; Klopfleisch R; Dunst S; Surma MA; Klose C; Rothe M; Heinzel FR; Krannich A; Kershaw EE; Beule D; Schulze PC; Marx N; Kintscher U
    PLoS Genet; 2018 Jan; 14(1):e1007171. PubMed ID: 29320510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
    Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
    Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
    Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
    Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Is Upregulated in Lymphocytes Stimulated with Concanavalin A.
    Simon-Molas H; Vallvé-Martínez X; Caldera-Quevedo I; Fontova P; Arnedo-Pac C; Vidal-Alabró A; Castaño E; Navarro-Sabaté À; Lloberas N; Bartrons R; Manzano A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TIGAR alleviates oxidative stress in brain with extended ischemia via a pentose phosphate pathway-independent manner.
    Liu M; Zhou X; Li Y; Ma S; Pan L; Zhang X; Zheng W; Wu Z; Wang K; Ahsan A; Wu J; Jiang L; Lu Y; Hu W; Qin Z; Chen Z; Zhang X
    Redox Biol; 2022 Jul; 53():102323. PubMed ID: 35576689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
    Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
    PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
    Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
    Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of TIGAR-TAK1 alleviates immunopathology in a murine model of sepsis.
    Wang D; Li Y; Yang H; Shen X; Shi X; Li C; Zhang Y; Liu X; Jiang B; Zhu X; Zhang H; Li X; Bai H; Yang Q; Gao W; Bai F; Ji Y; Chen Q; Ben J
    Nat Commun; 2024 May; 15(1):4340. PubMed ID: 38773142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fructose-2,6-bisphosphatase TIGAR suppresses NF-κB signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC.
    Tang Y; Kwon H; Neel BA; Kasher-Meron M; Pessin JB; Yamada E; Pessin JE
    J Biol Chem; 2018 May; 293(20):7578-7591. PubMed ID: 29650758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure.
    Pereira RO; Wende AR; Olsen C; Soto J; Rawlings T; Zhu Y; Riehle C; Abel ED
    J Mol Cell Cardiol; 2014 Jul; 72():95-103. PubMed ID: 24583251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wnt Signaling Activates TP53-Induced Glycolysis and Apoptosis Regulator and Protects Against Cisplatin-Induced Spiral Ganglion Neuron Damage in the Mouse Cochlea.
    Liu W; Xu X; Fan Z; Sun G; Han Y; Zhang D; Xu L; Wang M; Wang X; Zhang S; Tang M; Li J; Chai R; Wang H
    Antioxid Redox Signal; 2019 Apr; 30(11):1389-1410. PubMed ID: 29587485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.